CUTR : NASDAQ : Health Care
$23.5 up 1.2 | 5.38%
Today's Range: 22.35 - 24.15
Avg. Daily Volume: 99000.0
05/25/17 - 4:00 PM ET

Financial Analysis


CUTERA INC's gross profit margin for the first quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. The company grew its sales and net income significantly quarter versus same quarter a year prior, and was able to outpace the average competitor in the industry when comparing revenue growth, but not when comparing net income growth. CUTERA INC is extremely liquid. Currently, the Quick Ratio is 2.52 which clearly shows the ability to cover any short-term cash needs. CUTR managed to increase the liquidity from the same period a year ago, despite already having very strong liquidity to begin with. This would indicate improved cash flow.

During the same period, stockholders' equity ("net worth") has increased by 19.86% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY17 Q1 FY16
Net Sales ($mil)29.322.42
EBITDA ($mil)-1.17-1.93
EBIT ($mil)-1.41-2.17
Net Income ($mil)-1.02-2.05


Balance Sheet Q1 FY17 Q1 FY16
Cash & Equiv. ($mil)48.4344.45
Total Assets ($mil)88.2974.69
Total Debt ($mil)0.00.0
Equity ($mil)59.4449.59


Profitability Q1 FY17 Q1 FY16
Gross Profit Margin53.8256.7
EBITDA Margin-3.97-8.61
Operating Margin-4.82-9.68
Sales Turnover1.421.31
Return on Assets4.08-3.81
Return on Equity6.06-5.74
Debt Q1 FY17 Q1 FY16
Current Ratio3.213.16
Debt/Capital0.00.0
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q1 FY17 Q1 FY16
Shares outstanding (mil)13.7713.08
Div / share0.00.0
EPS-0.07-0.16
Book value / share4.323.79
Institutional Own % n/a n/a
Avg Daily Volume98223.090308.0

Valuation


HOLD. CUTERA INC's P/E ratio indicates a significant premium compared to an average of 41.69 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 25.02. For additional comparison, its price-to-book ratio of 4.63 indicates a significant premium versus the S&P 500 average of 3.00 and a discount versus the industry average of 4.72. The price-to-sales ratio is above the S&P 500 average, but well below the industry average.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
CUTR 76.92 Peers 41.69   CUTR 111.69 Peers 23.09

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

CUTR is trading at a significant premium to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

CUTR is trading at a significant premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
CUTR 30.53 Peers 23.68   CUTR 0.51 Peers 0.90

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

CUTR is trading at a significant premium to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

CUTR trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
CUTR 4.63 Peers 4.72   CUTR 223.80 Peers 126.02

Average. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

CUTR is trading at a valuation on par with its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

CUTR is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
CUTR 2.20 Peers 4.96   CUTR 27.33 Peers 14.58

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

CUTR is trading at a significant discount to its industry on this measurement.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

CUTR has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades